Chen, G., Sun, D., Ba, Y., Zhang, Y., Zhou, T., Zhao, Y., . . . Yang, Y. Anti-LAG-3 antibody LBL-007 plus anti-PD-1 antibody toripalimab in advanced nasopharyngeal carcinoma and other solid tumors: An open-label, multicenter, phase Ib/II trial. BMC.
Chicago Style (17th ed.) CitationChen, Gang, et al. Anti-LAG-3 Antibody LBL-007 Plus Anti-PD-1 Antibody Toripalimab in Advanced Nasopharyngeal Carcinoma and Other Solid Tumors: An Open-label, Multicenter, Phase Ib/II Trial. BMC.
MLA (9th ed.) CitationChen, Gang, et al. Anti-LAG-3 Antibody LBL-007 Plus Anti-PD-1 Antibody Toripalimab in Advanced Nasopharyngeal Carcinoma and Other Solid Tumors: An Open-label, Multicenter, Phase Ib/II Trial. BMC.
Warning: These citations may not always be 100% accurate.